iPS as modul system of cardiovascular disease
Chair: N. Frey (Kiel), M. Stumvoll (Leipzig)
(V819) | Optimization of human engineered heart tissue from induced pluripotent stem cells for cardiac repair | |
D. Köse, F. Weinberger, M. Reinsch, L. Castro, S. Pecha, I. Mannhardt, H. Reichenspurner, A. Hansen, T. Eschenhagen (Hamburg) | ||
Diskussion | ||
(V820) | Genomic Correction of Familial Dilated Cardiomyopathy Mutations in Patient-Specific iPSCs for Precision Medicine in Cardiovascular Disease | |
T. Pochechueva, P. L. Soong, M. Tiburcy, W.-H. Zimmermann, G. Hasenfuß, A. Ebert, für die Studiengruppen: DZHK Heart Failure Program Group, AG31, DZHK, AG12, AG8, AG18, AG22, AG13 (Göttingen) | ||
Diskussion | ||
(V821) | Patient-specific iPSC-derived cardiomyocytes reveal a disease-causing role of an ACTN2 mutation in HCM and an unexpected LQT phenotype | |
M. Lemoine, M. Prondzynski, G. Mearini, E. Krämer, M. Patten-Hamel, S. Willems, A. Hansen, T. Eschenhagen, T. Christ, L. Carrier (Hamburg) | ||
Diskussion | ||
(V822) | A patient-specific induced pluripotent stem cell Takotsubo-model for analyzing the catecholamine-dependent altered beta-adrenergic signaling | |
D. Hübscher, T. Borchert, D. T. Lam, H. Rawat, M. Tiburcy, N. Liaw, V. Nikolaev, S. T. Sossalla, W.-H. Zimmermann, C. Templin, G. Hasenfuß, K. Streckfuß-Bömeke (Göttingen, Hamburg, Regensburg; Zürich, CH) | ||
Diskussion | ||
(V823) | Keynote Lecture: State of the Art | |
A. Moretti (München) | ||
Diskussion |
17:45 - 19:45 | Opening Ceremony in hall 4 |